79 Years of Galenika: Growth is the Success of All Employees

79 Years of Galenika: Growth is the Success of All Employees

Belgrade, September 24, 2024 – In the year marking its 79th anniversary of leadership in the pharmaceutical industry, Galenika continues its steady growth through a significant expansion of its product portfolio and further internationalization of its operations. In the first seven months of 2024, Galenika registered as many as 90 new products in Serbia and regional markets, while increasing overall production by 18% compared to the same period last year. In the Serbian market, Galenika achieved an 18% increase in sales, while sales in the EU grew more than twofold. In addition to Serbia, Galenika successfully operates in 25 international markets and plans to expand to another 10 markets in Europe and the MENA region.

Galenika has 40 leading brands in its market categories in Serbia, and in partnership with EMS – the largest pharmaceutical company in Brazil, Galenika successfully carried out technology transfers for six more products in the first seven months of the year.

“This year, we are celebrating 79 years, recording constant growth, and our products are available on three continents – and this success belongs to the whole team. Users of our products know the brand and recognize Galenika as a guarantee of top-quality. We strive to continuously improve human lives through research and development, education, technology, networking, and investments. All employees who work at Galenika today, and those who have worked here in the past, have contributed to its growth and significance. Times are changing, but our people are, and will continue to be, our strength,” said Rikardo Vian Markes, CEO of Galenika.

Galenika is permanently focused on educating its employees and partners, as well as maintaining a responsible and sustainable business approach as one of the key pillars driving development. In the first seven months of the year, the total number of hours spent on employee training nearly tripled, and the company organized and sponsored 49 professional medical events for around 1,000 healthcare workers from Serbia. As a result of investments in renovating its internal water supply system, Galenika reduced its water consumption by more than half compared to the same period last year. Additionally, from January to July, Galenika made donations of medical equipment to two healthcare institutions and medication donations to 44 healthcare facilities in Serbia.

Galenika, a pharmaceutical company, was founded in 1945. At the end of 2017, it became part of the NC Group (www.gruponc.net.br), which also includes EMS – the largest pharmaceutical company in Brazil and one of the largest pharmaceutical companies in Latin America. Galenika manufactures generic drugs, dietary supplements, cosmetic products, medical devices, and items for general use. The Group’s strategy is to develop Galenika into a modern and flexible company, focused on research and development, continually improving its products to enhance health and quality of life for the benefit of its users.


Share:
824 PREGLEDA